We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current RVMD market cap is 6.14B. The company's latest EPS is USD -2.6496 and P/E is -0.14.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 3.36M | 15.33M | 7.01M | 3.82M | 0 |
| Operating Income | -76.53M | -61.71M | -75.16M | -108.8M | -123.25M |
| Net Income | -73.33M | -56.51M | -68.1M | -98.3M | -108.43M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 50.04M | 42.98M | 29.39M | 35.38M | 11.58M |
| Operating Income | -54.12M | -110.7M | -188.01M | -258.28M | -487.19M |
| Net Income | -61.9M | -110.38M | -187.09M | -248.71M | -436.37M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 825.91M | 811.93M | 1.07B | 1.07B | 984.23M |
| Total Liabilities | 144.49M | 126.74M | 121.03M | 142.87M | 146.77M |
| Total Equity | 681.42M | 685.19M | 952.22M | 930.84M | 837.46M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 220.53M | 567.4M | 737.99M | 811.93M | 2.06B |
| Total Liabilities | 67.99M | 92.73M | 135.42M | 126.74M | 235.51M |
| Total Equity | -152.57M | 474.68M | 602.57M | 685.19M | 1.83B |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -162.61M | -224.4M | -62.39M | -129.51M | -230.01M |
| Investing | -17.01M | -24.12M | 4M | -39.55M | 37.8M |
| Financing | 250.07M | 301.43M | 324.21M | 388.84M | 389.85M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -49.62M | -100.06M | -147.18M | -224.4M | -350.57M |
| Investing | -101.97M | -234.23M | -142.12M | -24.12M | -342.6M |
| Financing | 98.66M | 422.78M | 294.18M | 301.43M | 1.23B |
| Market Cap | 6.14B |
| Price to Earnings Ratio | -0.14 |
| Price to Sales Ratio | 5.26 |
| Price to Cash Ratio | 0.09 |
| Price to Book Ratio | 0.03 |
| Dividend Yield | - |
| Shares Outstanding | 164.69M |
| Average Volume (1 week) | 1.2M |
| Average Volume (1 Month) | 1.42M |
| 52 Week Change | 59.73% |
| 52 Week High | 38.73 |
| 52 Week Low | 15.4401 |
| Spread (Intraday) | 0.72 (1.89%) |
| Company Name | Revolution Medicines Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.revmed.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
